معرفی
Jeremy Hengst is an Assistant Professor in the Department of Pediatrics and the Department of Molecular and Precision Medicine at an unnamed institution (details not provided), affiliated with the Center for Cannabis and Natural Product Pharmaceuticals (CCNPP). His work focuses on sphingosine kinase (SK) and its role in cancer progression, particularly tobacco-carcinogen-induced lung cancer.
- Role of SK in cancer cell proliferation and survival
- Development of small-molecule SK inhibitors as anti-cancer agents
- Exploration of ceramide/S-1-P balance in apoptosis regulation
- Collaborative research on ER stress and immunogenic cell death
Dr. Hengst's recent research trends include targeted therapy development for lung and colorectal cancers, leveraging sphingolipid metabolism to enhance immunogenic cell death, and investigating collaborations with cannabinoid-based mechanisms. He received the Outstanding Collaborative Research Team award in 2015. Current projects involve validating SK inhibitors within the CCNPP framework, with a focus on precision oncology and lipid signaling pathways.
